Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
Title:
Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: A pilot study
Author:
Weisman, Michael H. Moreland, Larry W. Furst, Daniel E. Weinblatt, Michael E. Keystone, Edward C. Paulus, Harold E. Teoh, Leah S. Velagapudi, Raja B. Noertersheuser, Peter A. Granneman, G.Richard Fischkoff, Steven A. Chartash, Elliot K.